
Morepen Laboratories Limited has informed the Exchange regarding a press release dated March 17, 2025, titled "Empamore by Morepen: Revolutionizing Diabetes Care with Affordable, High-Quality Treatment ".
Filed with NSE · · 3 pages · English
Morepen Laboratories Limited has issued a press release announcing the launch of Empamore, a new treatment for diabetes and related conditions. Empamore is manufactured in USFDA-approved facilities and is positioned as a cost-effective alternative to existing treatments.
Written by 6ix AI from the company’s filing. How 6ix writes summaries

Morepen Laboratories Limited has informed the Exchange regarding a press release dated March 17, 2025, titled "Empamore by Morepen: Revolutionizing Diabetes Care with Affordable, High-Quality Treatment ".
Morepen Laboratories Limited on 6ix
Follow Morepen Laboratories into a list and get an email when it puts out news.
Follow Morepen Laboratories